Global /China /Healthcare /Biotechnology /600200

JiangSu WuZhong Pharmaceutical Development Co., Ltd.

600200

• SSE: 600200 • Delayed

0.2900CNY -9.4%

0.0429 USD

As of 15 June 2026, JiangSu WuZhong Pharmaceutical Development Co., Ltd. has a market cap of $30.13M USD, ranking #34226 globally and #6192 in China. It ranks #3088 in the Healthcare sector, and #594 in the Biotechnology industry.

Global Rank

34226

Country Rank

6192

Sector Rank

3088

Industry Rank

594

Key Stats

Market Cap

$30.13MUSD

203.88M CNY

Enterprise Value

$268.77MUSD

1.82B CNY

Revenue (TTM)

$162.57MUSD

1.1B CNY

EBITDA (TTM)

$2.71MUSD

18.33M CNY

Net Income (TTM)

-$9.17MUSD

-62.07M CNY

EBITDA Margin

1.7%

Profit Margin

-5.6%

Forward PE

0.6

PS Ratio

0.2

PB Ratio

0.1

EV/EBITDA

85.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Qunshan Qian open_in_new

Employees

1,096

Founded

1994

Website

600200.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-9.4%	-17%	-77%	-72%	-88%	-97%	-97%	-96%	-95%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600200 江苏吴中医药发展股份有限公司 Class A ISIN: CNE000000YP4 Shares Out.: Shares Outstanding: 709.558M¹ Shares Float: 586.99M² TV: TradingView: SSE: 600200 SA: Stock Analysis: SHA: 600200 YF: Yahoo Finance: 600200.SS GF: Google Finance: SHA: 600200 BA: Barron's: 600200 MS: Morningstar: XSHG: 600200	0.2900 CNY	TV: TradingView: SSE: 600200 SA: Stock Analysis: SHA: 600200 YF: Yahoo Finance: 600200.SS GF: Google Finance: SHA: 600200 BA: Barron's: 600200 MS: Morningstar: XSHG: 600200

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About JiangSu WuZhong Pharmaceutical Development Co., Ltd.

JiangSu WuZhong Pharmaceutical Development Co., Ltd. engages in pharmaceutical, medical cosmetology, investment, and other industries in China and internationally. It provides genetic and chemical drugs in the fields of anti-virus, anti infection, immune regulation, anti-tumor, digestive system, cardiovascular, etc.; and modern traditional Chinese medicine. The company also offers high-end injection filling products for medical cosmetology. It offers its products in various forms, such as hard capsules, granules, tablets, oral solutions, dropping pills, emulsions, large-volume injections, and small-volumes injections, powder injections, freeze-dried powder injections and raw materials, and other dosage forms. The company was founded in 1994 and is based in Suzhou, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.45B 136.71B HKD 58K%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 40K%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.01B 54.23B CNY 27K%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.34B 49.69B CNY 24K%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 23K%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.73B 45.52B CNY 22K%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 605K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 531K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 159K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.92B 68.19T KRW 149K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.46B 60.27B AUD 141K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 140K%	37.2	Switzerland

chevron_leftBack